Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $370

Benzinga · 01/07 15:55
Keybanc analyst Tim Rezvan maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $420 to $370.